Interferon-γ is not involved in the intestinal manifestations of the acute murine semiallogenic graft-versus-host disease

International Journal of Colorectal Disease

Volumn 16, Issue 5, 2001, Pages 346-351

  Stuber E ^a   Schlenger, P ^a   Von Freier, A ^a   Arendt, T ^a   Folsch U R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Crypt hyperplasia; Graft versus host disease; Interferon ; Interleukin 12; Interleukin 4; Villous atrophy

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 4; NEUTRALIZING ANTIBODY;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DONOR; ENTEROPATHY; GRAFT VERSUS HOST REACTION; HISTOLOGY; HYPERPLASIA; INTESTINE CELL; INTESTINE CRYPT; INTESTINE VILLUS ATROPHY; KNOCKOUT MOUSE; LAMINA PROPRIA; LYMPH NODE; LYMPHOCYTE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; INTESTINE, SMALL; MICE; MICE, KNOCKOUT;

EID: 0034804067     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840100322     Document Type: Article

References (31)

1. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
2. Cytokine regulation against parasitic gastrointestinal nematodes
3. The interleukin-12/interleukin-12-receptor system: Role in normal an pathologic immune responses
4. Blocking the CD40L-CD40 interaction in vivo specifically inhibits the priming of Th1-T cells
5. Antibodies to IL-12 abrogate established experimental colitis in mice
6. The cytokine modulation of acute graft-versus-host disease
7. IL-12 is a central mediator of acute graft-versus-host disease in mice
8. Gluten, major histocompatibility complex, and the small intestine
9. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction
10. Involvement of OX40-OX40L interactions in the intestinal manifestation of the murine acute Graft-versus-Host disease
11. Gut injury in mouse graft-versus-host reaction
12. Cloning of mouse Ox40: A T cell activation marker that may mediate T-B interactions
13. Lack of evidence for interferon-gamma as a mediator in a graft-rejection model of enteropathy
14. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors
15. Graft-versus-host disease: The influence of type 1 and type 2 cytokines
16. Interleukin-12 prevents severe acute graft-versus-host disease (GVHD) and GVHD-associated immune dysfunction in a fully major histocompatibility complex haplotype mismatched murine bone marrow transplantation model
17. Interleukin-12 inhibits murine graft-versus-host disease
18. Interferon-gamma-mediated prevention of graft-versus-host disease: Development of immune competent and allotolerant T cells in chimeric mice
19. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways
20. Interferon-gamma prevents graft-versus-host disease after allogenic bone marrow transplantation in mice
21. Donor-derived interferon γ is required for inhibition of acute graft-versus-host disease by interleukin-12
22. Administration of an IL-12-encoding plasmid prevents the development of chronic graft-versus-host disease (GVHD)
23. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogenic bone marrow transplantation in mice
24. Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental graft-versus-host disease
25. Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease
26. Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease
27. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ
28. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation
29. Interleukin-2 and interferon-γ producing cells in the lamina propria in celiac disease
30. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge
31. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon γ antibody